Libtayo fda approval history last updated by judith stewart, bpharm on oct 9, 2025 The following is a message from the director of the fda oncology center of excellence, dr Yes (first approved september 28, 2018) brand name
See important safety & full prescribing information. The fda approves eylea hd the treatment of patients with macular edema following retinal vein occlusion. Findings showed cemiplimab reduced the risk of disease recurrence or death by 68% compared with placebo
